Enteric bacteria and their antigens may stimulate postoperative peritoneal adhesion formation

Surgery

Volumn 141, Issue 3, 2007, Pages 403-410

  Cahill, Ronan A ^a   Wang, Jiang Huai ^a   Redmond, H Paul ^a  

^a University College Cork and INFANT Centre   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CYTOKINE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENTEROBACTERIACEAE; FLOW CYTOMETRY; LAPAROTOMY; MALE; MONOCYTE; MOUSE; NONHUMAN; PERITONEUM ADHESION; PERITONEUM MACROPHAGE; PERITONEUM MAST CELL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

ADHESIONS; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TRANSLOCATION; DISEASE MODELS, ANIMAL; ENTEROBACTERIACEAE; FLUORESCEIN-5-ISOTHIOCYANATE; LAPAROTOMY; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; PERITONEUM; PERITONITIS; POSTOPERATIVE COMPLICATIONS;

EID: 33847679063     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2006.09.010     Document Type: Article

References (57)

1. Ellis H., Moran B.J., Thompson J.N., Parker M.C., Wilson M.S., Menzies D., et al. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet 353 (1999) 1476-1480
2. Beck D.E., Opelka F.G., Bailey H.R., Rauh S.M., and Pashos C.L. Incidence of small-bowel obstruction and adhesiolysis after open colorectal and general surgery. Dis Colon Rectum 42 (1999) 241-248
3. DeCherney A.H., and diZerega G.S. Clinical problem of intraperitoneal postsurgical adhesion formation following general surgery and the use of adhesion prevention barriers. Surg Clin North Am 77 (1997) 671-688
4. Menzies D., Parker M., Hoare R., and Knight A. Small bowel obstruction due to postoperative adhesions: treatment patterns and associated costs in 110 hospital admissions. Ann R Coll Surg Engl 83 (2001) 40-46
5. Becker J.M., and Stucchi A.F. Intra-abdominal adhesion prevention: Are we getting any closer?. Ann Surg 240 (2004) 202-204
6. Ellis H. Intraabdominal and postoperative peritoneal adhesions. J Am Coll Surg 200 (2005) 641-644
7. Iuvone T., Den Bossche R.V., D'Acquisto F., Carnuccio R., and Herman A.G. Evidence that mast cell degranulation, histamine and tumour necrosis factor-α release occur in LPS-induced plasma leakage in rat skin. Br J Pharmacol 128 (1999) 700-704
8. Ecthenacher B., Mannel D.N., and Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381 (1996) 75-76
9. Malaviya R., Ikeda T., Ross E., and Abraham S.N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381 (1996) 77-80
10. Cahill R.A., Wang J., Sookhai S., and Redmond H.P. Mast cells facilitate local VEGF release as an early event in the pathogenesis of postoperative peritoneal adhesions. Surgery 140 (2006) 108-112
11. Liebman S.M., Langer J.C., Marshall J.S., and Collins S.M. Role of mast cells in adhesion formation. Am J Surg 165 (1993) 127-130
12. Langer J.C., Liebman S.M., Monk P.K., and Pelletier G.J. Mast cell mediators and peritoneal adhesion formation in the rat. J Surg Res 59 (1995) 344-348
13. Watson R.W., Redmond H.P., McCarthy J., Burke P.E., and Bouchier-Hayes D. Exposure of the peritoneal cavity of air regulates early inflammatory response to surgery in a murine model. Br J Surg 82 (1995) 1060-1065
14. Berger S.A. Mast Cells. In: Leftkovits I. (Ed). Immunology methods manual Vol 3 (1997), Academic Press, London (PA) 1418-1419 1404
15. Ivarsson M.L., Falk P., and Holmdahl L. Response of visceral peritoneum to abdominal surgery. Br J Surg 88 (2001) 148-151
16. Hill-West J.L., Dunn R.C., and Hubbell J.A. Local release of fibrinolytic agents for adhesion prevention. J Surg Res 59 (1995) 759-763
17. Falk K., Bjorquist P., Stromqvist M., and Holmdahl L. Reduction of experimental adhesion formation by inhibition of plasminogen activator inhibitor type 1. Br J Surg 88 (2001) 286-289
18. Verco S.J., Peers E.M., Brown C.B., Rodgers K.E., Roda N., and diZerega G. Development of a novel glucose polymer solution (icodextrin) for adhesion prevention: preclinical studies. Hum Reprod 15 (2000) 1764-1772
19. Thompson J.N., and Whawell S.A. Pathogenesis and prevention of adhesion formation. Br J Surg 82 (1995) 3-5
20. Tzianabos A.O., Cisneros R.L., Gershkovich J., Johnson J., Miller R.J., Burns J.W., and Onderdonk A.B. Effect of surgical adhesion reduction devices on the propagation of experimental intra-abdominal infection. Arch Surg 134 (1999) 1254-1259
21. Tan B., Wang J.H., Wu Q.D., Kirwan W.O., and Redmond H.P. Sodium hyaluronate enhances colorectal tumour cell metastatic potential in vitro and in vivo. Br J Surg 88 (2001) 246-250
22. Fabri P.J., and Rosemurgy A. Reoperation for small intestinal obstruction. Surg Clin North Am 71 (1991) 131-146
23. Corral J., Yelamos J., Hernandez-Espinosa D., Monreal Y., Mota R., Arcas I., et al. Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models. Am J Path 166 (2005) 1089-1098
24. van Hinsbergh V.W., Kooistra T., Scheffer M.A., Hajo van Bockel J., and van Muijen G.N. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 75 (1990) 1490-1497
25. Toh H., Torisu M., Shimura H., Kitsuki H., Uchiyama A., Itoh H., et al. In vitro analysis of peritoneal adhesions in peritonitis. J Surg Res 61 (1996) 250-255
26. Itaya H., Imaizumi T., Yoshida H., Koyama M., Suzuki S., and Satoh K. Expression of vascular endothelial growth factor in human monocyte/macrophages stimulated with lipopolysaccharide. Thromb Haemost 85 (2001) 171-176
27. Roy S., Clark C.J., Mohebali K., Bhatt U., Wallace W.A., Nahman N.S., et al. Reactive oxygen species and EGR-1 gene expression in surgical postoperative peritoneal adhesions. World J Surg 28 (2004) 316-320
28. Saltzman A.K., Olson T.A., Mohanraj D., Carson L.F., and Ramakrishnan S. Prevention of postoperative adhesions by an antibody to vascular permeability factor/vascular endothelial growth factor in a murine model. Am J Obstet Gynecol 174 (1996) 1502-1506
29. Molinas C.R., Binda M.M., Carmeliet P., and Koninckx P.R. Role of vascular endothelial growth factor receptor 1 in basal adhesion formation and in carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in mice. Fertil Steril 82 (2004) 1149-1153
30. Bothin C., Okada M., Midtvedt T., and Perpeck L. The intestinal flora influences adhesion formation around surgical anastomoses. Br J Surg 88 (2001) 143-145
31. Bothin C., Midtvedt T., and Perbeck L. Orally delivered antibiotics which lower bacterial numbers decrease experimental intra-abdominal adhesions. Langerbecks Arch Surg 388 (2003) 112-115
32. Oncel M., Kurt N., Remzi F.H., Sensu S.S., Vural S., Gezen C.F., et al. The effectiveness of systemic antibiotics in preventing postoperative intra-abdominal adhesions in an animal model. J Surg Res 101 (2001) 52-55
33. Zong X., Li S., Chen E., Garlick B., Kim K.S., Fang D., et al. Prevention of postsurgery-induced abdominal adhesions by electrospun bioabsorbable nanofibrous Poly(lactide-co-glycide)-based membranes. Ann Surg 240 (2004) 910-915
34. Treutner K.H., Bertram P., Lerch M.M., Klimaszewski M., Petrovic-Kallholm S., Sobesky J., et al. Prevention of postoperative adhesions by single intraperitoneal medication. J Surg Res 59 (1995) 764-771
35. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., et al. Defective signalling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
36. Qureshi S.T., Lariviere L., Leveque G., Clermont S., Moore K.J., Gros P., et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 189 (1999) 615-625
37. Bettinger D.A., Pellicane J.V., Tarry W.C., Yager D.R., Diegelmann R.F., Lee R., et al. The role of inflammatory cytokines in wound healing: accelerated healing in endotoxin-resistant mice. J Trauma 36 (1994) 810-814
38. Nolan J.P., Hae D.K., McDevitt J.J., and Ali M.V. In vitro studies of intestinal endotoxin absorption. I. Kinetics of absorption in the isolated everted gut sac. Gastroenterology 72 (1977) 434-439
39. Boesiger J., Tsai M., Maurer M., Yamaguchi M., Brown L.F., Claffey K.P., et al. Mast cells can secrete vascular permeability factor/vascular endothelial growth factor and exhibit enhanced release after immunoglobulin E-dependent up-regulation of Fce receptor I expression. J Exp Med 188 (1998) 1135-1145
40. Grutzkau A., Kruger-Krasagakes S., Baumeister H., Schwarz C., Kogel H., Welker P., et al. Synthesis, storage and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF. Mol Biol Cell 9 (1998) 875-884
41. Morrison D.C., and Betz S.J. Chemical and biological properties of a protein-rich fraction of bacterial lipopolysaccharides. II The in vitro rat peritoneal mast cell response. J Immunol 119 (1977) 1790-1795
42. Supajatura V., Ushio H., Nakao A., Okumura K., Ra C., and Ogawa H. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol 167 (2001) 2250-2256
43. Lorentz A., Schwengberg S., Sellge G., Manns M.P., and Bischoff S.C. Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4. J Immunol 164 (2000) 43-48
44. Malaviya R., and Abraham S.N. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J Leukoc Biol 67 (2000) 841-846
45. Biedermann T., Kneilling M., Mailhammer R., Maier K., Sander C.A., Kollias G., et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumour necrosis factor and macrophage inflammatory protein 2. J Exp Med 192 (2000) 1441-1452
46. Yao V., Platell C., and Hall J.C. Peritoneal mesothelial cells produce inflammatory related cytokines. ANZ J Surg 74 (2004) 997-1002
47. Bischoff S.C., Lorentz A., Schwengberg S., Weier G., Raab R., and Manns M.P. Mast cells are an important cellular source of tumour necrosis factor α in human intestinal tissue. Gut 44 (1999) 643-652
48. Clauss M., Sunderkotter C., Sveinbjornsson B., Hippenstiel S., Willuweit A., Marino M., et al. A permissive role for tumour necrosis factor in vascular endothelial growth-factor induced vascular permeability. Blood 97 (2001) 1321-1329
49. Ar'Rajab A., Mileski W., Sentementes J.T., Sikes P., Harris R.B., and Dawidson I.J. The role of neutrophils in peritoneal adhesion formation. J Surg Research 61 (1996) 143-146
50. Cheong Y.C., Laird S.M., Shelton J.B., Ledger W.L., Li T.C., and Cooke I.D. The correlation of adhesions and peritoneal fluid cytokine concentrations: a pilot study. Hum Reprod 17 (2002) 1039-1045
51. Steiner D.R., Gonzalez N.C., and Wood J.G. Mast cells mediate the microvascular inflammatory response to systemic hypoxia. J Appl Physiol 94 (2003) 325-334
52. Szukiewicz D., Gujski M., Maslinska D., Szewczyk G., Bachanek M., and Maslinski S. Mast cell-derived VEGF and VEGF receptor type 1, 2, and 3 expression in human term trophoblast culture-influence of hypoxia. Inflamm Res 54 Suppl 1 (2005) S82-S83
53. Elsbach P., and Weiss J. Role of the bactericidal/permeability-increasing protein in host defence. Curr Opin Immunol 10 (1998) 45-49
54. Elsbach P. The bactericidal/permeability-increasing protein (BPI) in antibacterial host response. J Leukoc Biol 64 (1998) 14-18
55. Hansbrough J., Tenenhaus M., and Wikstrom T. Effects of recombinat bactericidal/permeability-increasing protein (rBPI) on neutrophils activity in burned rats. J Trauma 40 (1996) 886-893
56. Wiezer M.J., Langendoen S.I., Meijer C., Bauer R.J., White M.L., Carroll S.F., et al. Pharmacokinetics of a recombinant amino terminal fragment of bactericidal/permeability increasing protein (rBPI121) after liver surgery in rats and humans. Shock 10 (1998) 161-166
57. Levin M., Quint P.A., Goldstein B., Barton P., Bradley J.S., Shemie S.D., et al. Recombinant bactericidal/permeability-increasing protein (rBPI) as adjunctive treatment for children with meningococcal sepsis: a randomised trial. Lancet 356 (2000) 961-967